From no options to new hope: How science, partnership and persistence are driving progress towards treatments for CASK 26 February 2026

https://rarerevolutionmagazine.com/from-no-options-to-new-hope-how-science-partnership-and-persistence-are-driving-progress-towards-treatments-for-cask/ SPONSORED CONTENT -THIS ARTICLE HAS BEEN FUNDED AND WRITTEN BY THE OXFORD-HARRINGTON RARE DISEASE CENTRE Matthew Wood and Matthew P. Anderson of the Oxford-Harrington Rare Disease Centre (OHC) highlight their commitment to driving progress for rare disease—impacting the lives of families like Cynthia Schulz and her daughter Noni who spent decades living without answers or effective treatments for CASK Written by Matthew Wood, MD, PhD, director and chief scientific officer, and Matthew P. Anderson, MD, PhD, co-director of the Oxford-Harrington Rare Disease Centre